USD 3.73
(6.27%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 37.79 Million USD | 9.6% |
2022 | 34.48 Million USD | -19.65% |
2021 | 42.91 Million USD | 16.77% |
2020 | 36.75 Million USD | 170.94% |
2019 | 13.56 Million USD | 54.98% |
2018 | 8.75 Million USD | 65.93% |
2017 | 5.27 Million USD | -75.18% |
2016 | 21.25 Million USD | 80.37% |
2015 | 11.78 Million USD | 34.12% |
2014 | 8.78 Million USD | 55.4% |
2013 | 5.65 Million USD | 83.68% |
2012 | 3.07 Million USD | 24.21% |
2011 | 2.47 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 35.46 Million USD | -6.17% |
2024 Q2 | 30.76 Million USD | -13.25% |
2023 Q2 | 33.31 Million USD | 1.14% |
2023 Q3 | 37.76 Million USD | 13.38% |
2023 FY | 37.79 Million USD | 9.6% |
2023 Q1 | 32.93 Million USD | -4.48% |
2023 Q4 | 37.79 Million USD | 0.07% |
2022 Q2 | 37.36 Million USD | -3.99% |
2022 Q3 | 28.37 Million USD | -24.08% |
2022 Q4 | 34.48 Million USD | 21.55% |
2022 FY | 34.48 Million USD | -19.65% |
2022 Q1 | 38.92 Million USD | -9.31% |
2021 Q3 | 45.45 Million USD | -0.3% |
2021 Q4 | 42.91 Million USD | -5.59% |
2021 Q1 | 33.91 Million USD | -7.73% |
2021 FY | 42.91 Million USD | 16.77% |
2021 Q2 | 45.59 Million USD | 34.44% |
2020 Q4 | 36.75 Million USD | 4.95% |
2020 Q1 | 32.63 Million USD | 140.58% |
2020 FY | 36.75 Million USD | 170.94% |
2020 Q2 | 46.54 Million USD | 42.63% |
2020 Q3 | 35.01 Million USD | -24.77% |
2019 Q1 | 12.28 Million USD | 40.37% |
2019 Q2 | 13.87 Million USD | 12.89% |
2019 FY | 13.56 Million USD | 54.98% |
2019 Q3 | 14.14 Million USD | 1.95% |
2019 Q4 | 13.56 Million USD | -4.07% |
2018 Q1 | 4.94 Million USD | -6.3% |
2018 Q2 | 5.24 Million USD | 6.19% |
2018 Q4 | 8.75 Million USD | -0.48% |
2018 Q3 | 8.79 Million USD | 67.56% |
2018 FY | 8.75 Million USD | 65.93% |
2017 FY | 5.27 Million USD | -75.18% |
2017 Q4 | 5.27 Million USD | -28.49% |
2017 Q3 | 7.37 Million USD | -52.84% |
2017 Q2 | 15.64 Million USD | -22.33% |
2017 Q1 | 20.13 Million USD | -5.26% |
2016 Q4 | 21.25 Million USD | 54.41% |
2016 FY | 21.25 Million USD | 80.37% |
2016 Q3 | 13.76 Million USD | 1.05% |
2016 Q2 | 13.62 Million USD | -3.26% |
2016 Q1 | 14.08 Million USD | 19.5% |
2015 Q3 | 10.99 Million USD | 29.5% |
2015 FY | 11.78 Million USD | 34.12% |
2015 Q4 | 11.78 Million USD | 7.14% |
2015 Q2 | 8.49 Million USD | -6.63% |
2015 Q1 | 9.09 Million USD | 3.53% |
2014 Q3 | 6.11 Million USD | 3.36% |
2014 Q1 | 5.88 Million USD | 4.14% |
2014 FY | 8.78 Million USD | 55.4% |
2014 Q2 | 5.92 Million USD | 0.55% |
2014 Q4 | 8.78 Million USD | 43.57% |
2013 Q3 | 6.08 Million USD | 0.0% |
2013 FY | 5.65 Million USD | 83.68% |
2013 Q1 | - USD | -100.0% |
2013 Q4 | 5.65 Million USD | -7.14% |
2012 FY | 3.07 Million USD | 24.21% |
2012 Q4 | 3.07 Million USD | 0.0% |
2011 FY | 2.47 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Inovalon Holdings, Inc. | 1.26 Billion USD | 97.007% |
GE HealthCare Technologies Inc. | 25.14 Billion USD | 99.85% |
Sharecare, Inc. | 125.56 Million USD | 69.898% |
Progyny, Inc. | 203.19 Million USD | 81.398% |
Aclarion, Inc. | 3.18 Million USD | -1085.688% |
CareMax, Inc. | 561.85 Million USD | 93.273% |
Simulations Plus, Inc. | 14.2 Million USD | -166.026% |
Forian Inc. | 33.19 Million USD | -13.859% |
Bullfrog AI Holdings, Inc. Warrants | 184.35 Thousand USD | -20402.848% |
Bullfrog AI Holdings, Inc. Common Stock | 184.35 Thousand USD | -20402.848% |
Minerva Surgical, Inc. | 51.71 Million USD | 26.919% |
Omnicell, Inc. | 1.03 Billion USD | 96.358% |
Definitive Healthcare Corp. | 626.72 Million USD | 93.969% |
Zhongchao Inc. | 3.37 Million USD | -1018.76% |
Accolade, Inc. | 342.68 Million USD | 88.97% |
Streamline Health Solutions, Inc. | 22.92 Million USD | -64.865% |
Ontrak, Inc. | 5.57 Million USD | -577.973% |
SOPHiA GENETICS SA | 54.71 Million USD | 30.919% |
R1 RCM Inc. | 2.2 Billion USD | 98.289% |
Spok Holdings, Inc. | 63.91 Million USD | 40.862% |
Privia Health Group, Inc. | 392.51 Million USD | 90.37% |
EUDA Health Holdings Limited | 8.79 Million USD | -329.88% |
HeartBeam, Inc. | 1.19 Million USD | -3065.578% |
GeneDx Holdings Corp. | 245.65 Million USD | 84.614% |
TruBridge, Inc. | 247.8 Million USD | 84.747% |
Nutex Health, Inc. | 319.13 Million USD | 88.157% |
Renalytix Plc | 15.82 Million USD | -138.829% |
Sharecare, Inc. | 125.56 Million USD | 69.898% |
Health Catalyst, Inc. | 334.89 Million USD | 88.714% |
10x Genomics, Inc. | 224.1 Million USD | 83.134% |
GoodRx Holdings, Inc. | 826.84 Million USD | 95.429% |
SCWorx Corp. | 2.42 Million USD | -1458.79% |
Schrödinger, Inc. | 254.39 Million USD | 85.143% |
HealthEquity, Inc. | 1.2 Billion USD | 96.854% |
HealthStream, Inc. | 159.19 Million USD | 76.257% |
MSP Recovery, Inc. | 1.74 Billion USD | 97.829% |
Augmedix, Inc. | 43.39 Million USD | 12.892% |
BrightSpring Health Services, Inc. Common Stock | 5.17 Billion USD | 99.27% |
Ontrak, Inc. | 5.57 Million USD | -577.973% |
SHL Telemedicine Ltd. | 36.58 Million USD | -3.304% |
CareCloud, Inc. | 37.79 Million USD | 0.0% |
Premier, Inc. | 1.46 Billion USD | 97.422% |
Certara, Inc. | 516.29 Million USD | 92.679% |
GeneDx Holdings Corp. | 245.65 Million USD | 84.614% |
OneMedNet Corporation | 13.32 Million USD | -183.705% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 5.17 Billion USD | 99.27% |
EUDA Health Holdings Limited | 8.79 Million USD | -329.88% |
HeartBeam, Inc. | 1.19 Million USD | -3065.578% |
CareCloud, Inc. | 37.79 Million USD | 0.0% |
Mangoceuticals, Inc. | 276.03 Thousand USD | -13592.63% |
CareMax, Inc. | 561.85 Million USD | 93.273% |
Healthcare Triangle, Inc. | 9.51 Million USD | -297.403% |
National Research Corporation | 73.48 Million USD | 48.563% |
Aclarion, Inc. | 3.18 Million USD | -1085.688% |
OptimizeRx Corporation | 56.82 Million USD | 33.48% |